Energy stocks hedge funds like, consider sleaze when investing, CME-CBOE merger, Raj silent and more
By Chris ClairWhat’s news around the hedge fund industry for Wednesday, July 18, 2012:
Around the web
Six popular energy stocks amongst hedge funds. (Benzinga)
If little else, Brian Stoker’s trial may show Wall Street’s foolishness. (DealBook)
Not all investors are equal. (NYT op-ed)
Sleaze factors into investing decisions. (Gail Marks Jarvis in the Chicago Tribune)
Act now to avert a new Great Depression, economist Duncan says. (Reuters)
LIBORious I: Mervyn King put LIBOR reform on central banker meeting agenda: source. (Reuters)
LIBORious II: Letters shed light on 2008 concerns about LIBOR manipulation. (Barron’s)
BlackRock bond trading platform test skips banks. (WSJ.com)
Rajaratnam silent in tax-shelter deposition, lawyer says. (Bloomberg)
Obama official calls for tough, simple Volcker rule. (Deal Journal)
PFGBest case leads to unique roles for trustee, receiver. (Fox Business)
CME seen needing CBOE as profit woes spur speculation. (Bloomberg)
High-frequency trauma – what unintended consequences are in store as regulators target HFT? (Automated Trader Magazine)
Eric Hovde reports putting $4 million of his own money into senate campaign. (Wisconsin State Journal)
Daniel Shak drops $1 million shoe collection case against ex-wife Beth Shak. (The Telegraph)
James Chanos says he’s shorting Hewlett-Packard. (Deal Journal)
HP tanks on Chanos critique, instantly rebounds. (Benzinga)
Asset managers worldwide facing ‘avalanche’ of regulation. (IPE.com)
Surge in biotech deals to unlock big investor profits. (Reuters)
U.S. futures watchdogs to require online access to brokers’ banks. (Reuters)
People moves
Capula Investment Management hires former BofA exec Steven Zander. (HedgeFund.net)
